SIA "Ingen Pharma"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 504 006 € (13% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2011–2025
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||||
| Total current assets | 171 239 | 138 666 | 227 968 | 484 473 | 598 851 | 1 023 207 | 1 334 999 | 1 999 416 | 2 338 367 | 1 936 522 | 2 613 920 | 3 331 475 | 4 056 487 | 1 945 063 | 2 445 658 |
| Total non-current assets | 416 965 | 503 595 | 482 963 | 823 659 | 1 052 341 | 1 173 946 | 996 977 | 900 962 | 608 128 | 363 673 | 193 494 | 108 111 | 125 153 | 3 215 468 | 3 237 786 |
| Total assets | 588 204 | 642 261 | 710 931 | 1 308 132 | 1 651 192 | 2 197 153 | 2 331 976 | 2 900 378 | 2 946 495 | 2 300 195 | 2 807 414 | 3 439 586 | 4 181 640 | 5 160 531 | 5 683 444 |
| Balance sheet — liabilities and equity | |||||||||||||||
| Current liabilities | 310 626 | 739 916 | 747 219 | 1 156 992 | 1 335 121 | 955 295 | 1 060 124 | 2 048 886 | 1 864 856 | 740 980 | 664 805 | 582 067 | 397 048 | 1 210 916 | 1 675 988 |
| Non-current liabilities | 517 155 | 0 | 0 | 0 | 0 | 765 000 | 765 000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155 |
| Total liabilities | 827 781 | 739 916 | 747 219 | 1 156 992 | 1 335 121 | 1 720 295 | 1 825 124 | 2 048 886 | 1 864 856 | 740 980 | 664 805 | 582 067 | 397 048 | 1 210 916 | 1 676 143 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -242 140 | 138 773 | 62 564 | 196 308 | 164 863 | 170 898 | 29 994 | 344 640 | 230 147 | 477 576 | 583 394 | 714 910 | 927 073 | 165 023 | 561 692 |
| Total equity | -240 140 | -101 367 | -38 803 | 141 097 | 305 960 | 476 858 | 506 852 | 851 492 | 1 081 639 | 1 559 215 | 2 142 609 | 2 857 519 | 3 784 592 | 3 949 615 | 4 007 301 |
| Income statement | |||||||||||||||
| Sales revenue | 66 280 | 488 317 | 631 143 | 1 315 551 | 2 057 110 | 3 531 004 | 3 710 097 | 3 787 547 | 3 929 945 | 3 812 350 | 4 007 534 | 5 068 266 | 5 182 022 | 4 748 745 | 5 098 411 |
| Operating profit | -231 600 | 171 173 | 76 557 | 248 005 | 214 282 | 215 260 | 59 371 | 368 621 | 254 924 | 478 100 | 585 008 | 718 862 | 842 637 | 50 750 | 431 772 |
| EBITDA | -226 541 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit before income tax | -242 140 | 138 773 | 65 804 | 232 705 | 198 982 | 200 086 | 36 421 | 345 671 | 230 915 | 477 985 | 585 008 | 718 862 | 930 160 | 167 582 | 561 692 |
| Profit for the reporting year | -242 140 | 138 773 | 62 564 | 196 308 | 164 863 | 170 898 | 29 994 | 344 640 | 230 147 | 477 576 | 583 394 | 714 910 | 927 073 | 165 023 | 561 692 |
| Labour costs | 14 876 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | 5059 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||||
| Employees | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 504 006 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Summary: SIA "Ingen Pharma"
Overview
SIA "Ingen Pharma" (reg. no. 40103366338) is a limited liability company. The company was registered in 2011 and has been in the register for 15 years. Registered address: Mārupes nov., Mārupe, Kārļa Ulmaņa gatve 119.
Financial results
Revenue in 2025 was 5 098 411 €, up 7,4% on the previous year (4 748 745 €). From 2011 to 2025, revenue grew by an average of 36,4% per year. Net profit for 2025 was 561 692 € (11,0% of revenue). The company was profitable in 14 of the 15 published years. In 2025 the company had 3 employees. Revenue per employee was 1 699 470 €. At the end of 2025, total assets were 5 683 444 € and equity 4 007 301 € (70,5% of assets).
Management and owners
The company has one board member. The sole owner of the company is Uždaroji akcine bendrove "Nemuno vaistine".
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.